-hydrogenases catalyze the interconversion between protons and hydrogen through a complex di-iron active site consisting of CO and CN -ligands, and a non-protein dithiolate bridge. The structure of the enzyme suggested the bridge to be SCH 2 XCH 2 S, with X being either C, N or O. This site is synthesized and assembled by two ''Radical-S-adenosylmethionine (SAM or AdoMet)'' iron-sulfur enzymes, HydE and HydG, and one GTPase, HydF. HydE may be involved in CN -synthesis [1]. HydG displays significant amino acid sequence homology with ThiH, an enzyme that uses AdoMet to cleave tyrosine into p-cresol and dehydroglycine. The homology between these two AdoMet-dependent proteins and our finding of a similar cleavage reaction carried out by HydG provide new insights into the mechanism of hydrogenase maturation. HydG may be specifically involved in the synthesis of the dithiolate bridging molecule, with two tyrosine-derived dehydroglycines as precursors along with an [FeS] cluster of HydG functioning both as electron shuttle and source of the sulfur atoms [2]. According to this mechanism, both N and O are possible bridgehead atoms although we favor the former because, as shown by model chemistry [3], an amine is a more suitable base than an ether.
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Electrons from hydrogen: a remarkable insight into hydrogenase Center for Future Chemistry, Kyushu University, 744 Moto-oka, Nishi-ku, Fukuoka 819-0395, Japan. 2 CREST, JST, Kawaguchi Center Building, 4-1-8, Honcho, Kawaguchi, Saitama 332-0012, Japan. ogo-tcm@mbox.nc.kyushu-u.ac.jp The growing need for hydrogen-based fuel cells has driven research into hydrogenase (H 2 ase)-a natural enzyme that catalyses the extraction of electrons from H 2 in water under ambient conditions. Unfortunately, the exact mechanism by which H 2 ase achieves this feat has remained a matter of some controversy until now, with many mechanisms being inconsistent with experimental data. Recently, however, we have been able to produce a successful catalytic mimic of H 2 ase that replicates key aspects of it. I begin with an overview of the research from many groups that preceded this discovery, followed by a detailed analysis of the key points that set our unique functional model apart-that is to say a proton-like ''hydride'' species, a surprisingly low-valent Ni I Ru I complex and the key insight that two molecules of H 2 are required for electron extraction. [1] [2] [3] . The efficiency of these natural catalysts approaches that of platinum currently used in fuel cells, yet nature's uniquely constructed binding sites permit abundant base metals, iron and nickel, to function as does platinum. Investigations of small molecule models of the [FeFe] and [NiFe] H 2 ases have led to the understanding of essential properties of homo-and heterobimetallics that might account for the low overpotentials for H 2 production in the enzyme. Augmented by information from the single iron hydrogenase [3] , a hydrogen-capture, redox-inactive metalloprotein, knowledge may be applied toward the optimization of electrocatalysts for proton reduction/H 2 production and H 2 oxidation. Certain aspects of approaches to the immobilization of such biomimetics on solid supports and potential electrode materials and to the development of new bio-inspired fundamental chemistry will be presented. Institute of Inorganic Chemistry, University of Vienna, 1090 Vienna, Austria. alexey.nazarov@epfl.ch Currently, ruthenium complexes are amongst the most promising nonplatinum metal-based anticancer agents. In particular, organometallic Ru-arene complexes with the ''piano-stool'' geometry were shown to possess antimetastatic and tumor-inhibiting properties. Attaching a carbohydrate moiety to a metal center provides new complexes that exploit the biochemical and metabolic functions used for sugars in living organisms for transport and accumulation [1] . The synthesis of new sugar-linked ruthenium(II)-and osmium(II)-arene complexes and their characterization in terms of cytotoxicity and stability will be presented. The structural modification with regard to the arene ligand, the leaving group, and the nature the metal centers is discussed. The authors are indebted to EU for a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme project 220890-SuRuCo. ulrich.schatzschneider@rub.de Carbon monoxide is an important small molecule messenger in the human body. To study its biological activity and explore potential medicinal applications, there is a steadily growing interest in the use of metal carbonyl complexes as a solid storage form for carbon monoxide in CO releasing molecules (CORMs). In addition, the strong m(CO) vibrations at wavelengths where the constituents of bio(macro)molecules do not show any signals make it very attractive to use them as intrinsic markers of CORM biodistribution in Raman microscopy studies. We will present our latest results on the preparation of functionalized M(CO) 3 complexes and their peptide bioconjugates for a targeted delivery to cancer cells and their biological properties. A number of new systems with both photoinduced and dark cytotoxicity against different cancer cell lines will be discussed.
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Amide linkage isomerism as an activity switch in organometallic osmium and ruthenium anticancer complexes has shown that their aqueous reactivity, stability and cancer cell cytotoxicity are highly dependent on the nature of the chelating ligand YZ [1] . In this study, Os II and Ru II arene compounds using N-Phpicolinamide derivatives as chelating ligands (YZ) that can act as N,N-or as N,O-donor have been prepared. The coordination mode adopted is dependent on the electronic and steric effects of the functional groups on the phenyl ring (Fig. 1) . Solid state structures, cytotoxic data and investigations of the aqueous chemistry of the Os II and Ru II compounds in relation to their coordination modes are discussed. The N,N-and N,O-coordination modes resulted in Os II and Ru II complexes that display dramatic differences in their biological reactivity. We thank the University of Warwick (studentship for SvR), Science City (AWM) and EPSRC for funding, and members of COST D39 for stimulating discussions. The bioavailability of polyphenols is a current challenge for pharmaceutical and agri-food industries. We have succeeded in obtaining effective formulations in nanocapsule form with Fc-diOH, allowing a delayed diffusion of the active principle [2, 3] . The local delivery of Fc-diOH lipid nanocapsules followed by external radiotherapy provides a synergistic treatment against intracranial 9L gliomas xenograft. It appeared that 20% of the rats were ''long-term survivors''. Therefore, selected bioorganometallic species provide a new line of attack for problem of high social importance.
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Bioorganometallic chemistry: synthesis, mechanistic studies, and biology of g 2 -N,O and g 6 -Cp*Rh-hydroxytamoxifen complexes Richard H. Fish Lawrence Berkeley National Laboratory, 70-108B, University of California, Berkeley, CA 94720, USA. rhfish@lbl.gov Organometallic pharmaceutical chemistry and biology has now been recognized as a viable discipline for drug discovery. We have focused on the chemistry and biology of a class of potential breast cancer drugs, the cis-and trans-Cp*Rh-hydroxytamoxifen derivatives. We discovered that the kinetically formed cis-and trans-g 2 -N,O complexes underwent a novel, regioselective, intramolecular N-p rearrangement to the thermodynamically stable g 6 complexes, which were found to be cytotoxic to breast cancer cells [1] . An extensive DFT study provided a plausible pathway for this novel N-p rearrangement [2] . Computer docking studies of the cis-g 6 complex to the estrogen receptors, ERa and ERb, showed the binding modes. These g 6 -Cp*Rh/Cp*Ru-hydroxytamoxifen complexes could also be utilized as single molecule fluorescent probes for biological studies.
M-10 Conjugation of organometallic compounds and biomolecules
Toshikazu Hirao, Toshiyuki Moriuchi Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Yamada-oka, Suita, Osaka 565-0871, Japan. hirao@chem.eng.osaka-u.ac.jp Highly ordered molecular assemblies are constructed in bio-systems to fulfill unique functions as observed in enzymes, receptors, etc. Introduction of functional complexes into highly ordered biomolecules is considered to be a convenient approach to novel biomaterials, bio-inspired systems, etc. The research field of bioorganometallic chemistry, which is a hybrid area between biochemistry and organometallic chemistry, has recently received extensive interest. Conjugation of organometallic compounds with biomolecules such as peptides and nucleobases has been focused on for the design of the bioconjugates in our laboratory. Potential utilization of ferrocene as a molecular scaffold to mimic a central reverse-turn unit permits the investigation on the hydrogen bonding properties of peptide strands. A variety of ferrocene-peptide bioconjugates have been synthesized to induce the highly ordered structures of peptides for new biomaterials [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . The sequence and configuration of amino acids are key factors to construct various chirality-organized bio-inspired systems. Another design depends on the use of bio-like polymers as a backbone. Luminescent organometallic compounds are arrayed around the backbone of poly-L-glutamic acid to induce the metal-metal interaction, exhibiting an emission based on metal-metal-to-ligand charge transfer (MMLCT) transition.
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A bioorganometallic approach to monitor protein kinase-catalyzed phosphorylations Heinz-Bernhard Kraatz Department of Chemistry, The University of Western Ontario, 1151 Richmond Street, London N6A 5B7, Canada. hkraatz@uwo.ca During protein phosphorylation, a phosphate group is transferred from ATP to specific serine, threonine, or tyrosine residues of a protein. This reaction is catalyzed by protein kinases. In this paper, an electrochemical method for following this enzymatic reaction is outlined, which is based on the use of the organometallic conjugate adenosine 5 0 -[c-ferrocene] triphosphate (ATP-Fc) [1, 2] . Protein kinases use Fc-ATP and transfer a c-phosphate-Fc group rendering a surface-bound peptide substrate redox active. This reaction can be detected and quantified. Results are presented for serine/threonine and tyrosine kinases allowing us to assess the activity of kinase activity and measure inhibition of kinase activity.
EPR of Co(II) complexes, however, suffers from limitations originating from the zero-field splitting in the resulting high-spin (S = 3/2) ground state. We have overcome these limitations through the use of a high-frequency and -field version of EPR (HFEPR), and have been able to extract intrinsic (as opposed to effective) spin Hamiltonian parameters as well as link them to the electronic structure of several Co(II) scorpionate complexes. This information may have a bearing on structural-electronic correlations in zinc enzymes (Fig. 1 ).
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Nickel biomimetics for the active site of urease and their catalysis towards the conjugate addition of thiols to a,b-enones Centre of Molecular Biosciences, University of Innsbruck, Austria. bernhard.kraeutler@uibk.ac.at The recent discovery of riboswitches revealed direct metabolite binding to RNA and a new mechanism of control of gene expression involving untranslated regions at the 5 0 -end of mRNA [1] . B 12 -riboswitches specifically depend on the binding of vitamin B 12 -derivatives to mRNA, resulting in a switch of the RNA structure and in an altered gene expression. Here, we report on the complementary ''reverse B 12 -riboswitches'', in which binding of suitably arranged RNA induces the bound organometallic B 12 -derivative to switch from its usual ''base-on'' form into ''base-off'' [2] . By such a switch, the reactivity of the bound B 12 -derivative can be altered considerably, offering the opportunity for enhanced reactivity in organometallic catalysis. Accordingly, reverse B 12 -riboswitches may be of interest as an entry to organometallic B 12 -dependent ribozymes. Such constructs could be of relevance in the context of the RNA-world hypothesis and other questions of the chemical evolution of catalysis in early forms of life. Support by the Austrian National Science Foundation (FWF) and by the European Commission is gratefully acknowledged.
